Transforming Technology into Commercially Relevant Products
Bridging the gap between disruptive technological innovations and market-ready solutions is one of the biggest challenges in the life sciences sector. Many promising discoveries in universities and federal labs struggle to reach commercialization due to a lack of resources, entrepreneurial expertise, and strategic guidance. The Entrepreneur-in-Residence (EIR) Program at BioHealth Innovation, Inc. (BHI) is designed to address these challenges by providing the critical support needed to transform groundbreaking technologies into commercially viable products that can have a measurable impact on human health.
Our Approach
The EIRs at BHI take a hands-on approach, working closely with entrepreneurs to understand their technology, the problem they aim to solve, and the market they intend to serve. Here’s how the process works:
Initial Engagement
We start by getting to know you, the entrepreneur, and your technology. This initial phase allows both parties to assess the potential for a collaborative relationship.
During this stage, a memorandum of understanding (MOU) is signed to establish an exclusive working relationship.
Deeper Due Diligence
Following the initial engagement, we enter a consulting agreement for a defined period. This phase, often referred to as the “courting phase,” involves a thorough evaluation of the technology’s commercial potential, the market landscape, and the strategic plan. Both you and the EIR work together to refine the commercialization strategy and assess the feasibility of moving forward.
Formal Client Agreement
Upon successful completion of the courting phase, we formalize the relationship with a client agreement. From this point onward, we operate as a unified team, fully committed to your success. BHI supports you in making key connections, refining commercial strategies, pitching to potential investors, and achieving critical milestones that will propel your company to the next stage.
Supporting a Broad Spectrum of Technologies
BioHealth Innovation, Inc. is committed to advancing technologies that have the potential to make a real difference in human health. Our EIRs work with a diverse range of innovations, including therapeutics, medical devices, diagnostic tools, research tools, and mobile/health IT technologies. We are particularly interested in collaborating with energetic entrepreneurs and scientists who are passionate about solving unmet medical needs and improving patient outcomes.
Doing Well by Doing Good:
Our Commitment
At BHI, we believe in the principle of “Doing Well by Doing Good.” This ethos drives everything we do, from the way we engage with entrepreneurs to the impact we strive to achieve through our support of life sciences innovation. We seek out partners who share this commitment to making a positive difference in the world through their work.
The BioHealth Innovation EIR program supports biohealth companies, entrepreneurs, universities, NIH, and ARPA-H. Seasoned industry experts mentor startups and early-stage companies through the commercialization process, providing invaluable insights and support
Why Partner with BHI?
With BHI’s EIR Program, you gain more than just access to resources—you gain a strategic partner dedicated to helping you navigate the complexities of bringing a new technology to market. Our EIRs, particularly those working within NIH and ARPA-H, are uniquely positioned to offer insights and connections that can accelerate your journey from discovery to commercialization. We’re here to ensure that your innovation not only reaches the market but also achieves its full potential in making a meaningful impact on human health.
Entrepreneurs interested in joining the EIR Program are urged to contact:
Rich Bendis, President & CEO
rbendis@biohealthinnovation.org